Many medical experts, including career FDA scientists, say there isn't enough data and research to prove the peptides are safe and effective, warning of possible quality control problems, contamination risks, and the potential for dangerous allergic reactions
Increase fullness signals so patients need less food to feel satisfied
Semaglutide is currently the most prominent approved option in this class: Ozempic (semaglutide injection) licensed for type 2 diabetes management Wegovy (semaglutide 2.4 mg injection) licensed specifically for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
You will likely get the most from Pep if you: Use an Android phone or a mix of devices
The fit depends on whether you value platform breadth or category focus, plus cost and structure
Greater weight loss during treatment was associated with greater rebound, suggesting biological adaptations, potentially involving changes in appetite hormones, metabolism, or reward sensitivitythat increase susceptibility to weight regain [141]